Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,970 public trials 1,744 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, Not Recruiting

PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)

NCT06750432

Conditions
Alzheimer Disease, Alzheimer Disease, Early Onset, Brain Diseases, +7 more
Locations
  • Irvine Center for Clinical Research Irvine, California, United States
  • Healthy Brain Research Long Beach, California, United States
  • JEM Research Institute Atlantis, Florida, United States
  • Quantum Laboratories Deerfield Beach, Florida, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease

NCT03100149

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Uab Medicine Birmingham, Alabama, United States
  • Barrow Neurology Clinics Phoenix, Arizona, United States
  • Neurology Center of North Orange County Fullerton, California, United States
  • USC Keck Medical Center of USC Los Angeles, California, United States
View all 55 locations
View Trial Details
Active, Not Recruiting

Study in Parkinson Disease of Exercise

NCT04284436

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

NCT03962543

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations
  • University of Alabama at Birmingham/Children's of Alabama Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

NCT03779334

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations
  • Nemours Children's Hospital Orlando, Florida, United States
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Chr de La Citadelle Liège, Belgium
  • Hospital das Clinicas - FMUSP_X São Paulo, Brazil
View Trial Details
Active, Not Recruiting

A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec

NCT05575011

Conditions
Central Nervous System Diseases, Healthy Volunteer, Motor Neuron Disease, +5 more
Locations
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Children's Hospital of Eastern Ontario Ontario, Canada
  • Hôpital Armand Trousseau Paris, France
  • Universitatsklinikum Essen Essen, Germany
View all 17 locations
View Trial Details
Active, Not Recruiting

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

NCT05335876

Conditions
Atrophy, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +19 more
Locations
  • Child Hosp Of The Kings Daughters Norfolk, Virginia, United States
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Curitiba, Paraná, Brazil
View all 32 locations
View Trial Details

Related conditions